For more updates follow srinivasulutirumalasetty.blogspot.com
To get global pharma news updates in whatsapp please
Showing posts with label EXPERIENCE. Show all posts
Showing posts with label EXPERIENCE. Show all posts
Monday, 20 November 2023
Tuesday, 30 May 2023
EUGIA PHARMA SPECIALITIES LTD, WALK IN INTERVIEW FOR FRESHERS & EXPERIENCE ON 03rd JUNE, 2023 @ HYDERABAD
For more updates follow
To get global pharma news updates in whatsapp please
Sunday, 11 September 2022
AUROBINDO PHARMA LTD HIRING CANDIDATES FOR TTD (TECHNOLOGY TRANSFER) @ NAIDUPETA , NELLORE
ABOUT COMPANY :
Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
VACANCY DETAILS :
Send Resumes Who are willing to relocate Nayudupeta Only
Send RESUMES On and before 17/09/2022
COMPANY : Aurobindo Pharma Ltd
JOB LOCATION : Nayudupeta , Nellore (Dt), Andra Pradesh
DEVISON : Formulation
DEPARTMENTS: TTD (TECHNOLOGY TRANSFER)
Designation : Executive and Sr.executive
QUALIFICATION : B.Pharm/ M.Pharm
EXPERIENCE : Should have minimum experience of 2-8 years.
For more updates follow
To get global pharma news updates in whatsapp please
JODAS EXPOIM PVT LTD WALK IN INTERVIEW FOR FR&D AND AR&D ON 16 th, SEPTEMBER, 2022 @ KARKAPATLA, SIDDIPETA , TELANGANA
ABOUT COMPANY :
Jodas is a Global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
Jodas focuses its operations on four speciality therapeutic segments:
· Anti Infectives (Injectables & Orals)
· Anti Cancer (Injectables & Orals)
· Contrast Media – Injectables
· Critical Care (Injectables & Orals)
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.
Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.
We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.
Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.
For more updates follow
To get global pharma news updates in whatsapp please
GRANULES INDIA LTD WALK IN INTERVIEW ON 12 th, SEPTEMBER, 2022 @ HYDERABAD
ABOUT COMPANY :
Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.
As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.
For more updates follow
To get global pharma news updates in whatsapp please
Sunday, 10 April 2022
Formulation Development and Technology Transfer Vacancy @ STRIDES BANGALORE
Department : Formulation Development and Technology Transfer
Experience : 2 to 5 years
Position : Executive
Company name : Strides, Bangalore.
Interested candidates send resume to
Thursday, 28 October 2021
EUGIA PHARMA SPECIALITIES LTD WALK IN INTERVIEW ON 31st, OCTOBER, ,2021 @ HYDERABAD
For more updates follow
To get global pharma news updates in whatsapp please
IPCA LABORATORIES LTD WALK IN INTERVIEW ON 31st, OCTOBER, 2021 @ ATHAL, SILVASSA
ABOUT COMPANY :
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949.
When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti.
This, is how Ipca works.
For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.
Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.
Taking the industry forward
- One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally
- 15 APIs & 11 Formulations manufacturing facility across the globe
- Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India
- 4 formulations rank amongst the top 300 brands of Indian Pharmaceutical Market as per IQVIA May 2020
For more updates follow
To get global pharma news updates in whatsapp please
ALEMBIC PHARMA WALK IN INTERVIEW ON 31st, OCTOBER, ,2021 @ VADODARA, GUJARAT
For more updates follow
To get global pharma news updates in whatsapp please
EMCURE PHARMACEUTICALS LTD WALK IN INTERVIEW ON 30th, 31st, OCTOBER, ,2021 @ SANAND, AHMEDABAD
ABOUT COMPANY :
Emcure Pharmaceuticals Ltd. was incorporated on 16th April, 1981. The Group has emerged as significant force in manufacturing and marketing both in India and Globally.
The core strength lies in developing and manufacturing differentiated pharmaceutical products in – house and commercializing the same through marketing infrastructure across the geographies.
The group is ranked as the 12th largest Pharmaceutical company (source: AIOCD-AWACS MAT MAR 19) in India.
The Group has emerged as a leader in various therapy segments like Cardiology, Pain and Analgesics, HIV, Gynecology, Nephrology, Cephalosporin Injectable, Hepatology, Oncology, Diabetology, Vitamins – Minerals & Nutrients as well as Blood products.
The group has gained significant advantage due to its diversified / specialized group companies like Zuventus, Gennova and Heritage. Headed by a professional team each of this group has utilized their own strengths across therapy segments and geographies and know-how to make the group stronger and well entrenched.
The group products are available globally over 65 countries and enjoy the alliance of local and multinational companies to attain leadership.
The group has subsidiaries in Dubai, Brazil, South Africa, Singapore and Nigeria and branch offices in Russia, Morocco and Shanghai.
The group has nine manufacturing facilities including eight in India and one in United States, five of which are approved by USFDA.
Our quality is respected in India and world over and is testimonial of our supplies to leading multinationals.
Our group is respected as a reliable and proven co- marketing partner, evident through our collaborative relationship with companies like Sanofi, Roche, B.M.S etc.
We offer technological expertise across various areas like API’s (First to market opportunities in domestic markets), Bio Similars, Novel Drug Delivery Systems, Paragraph IV opportunities in US, wide expertise with various dosage forms, Chiral molecules, Peptides, Polymer based chemistry & complex products.
Through Zuventus the group has emerged as a leader in Acute & Semi Chronic therapies in Indian Pharmaceutical Market. For further info click and access www.emcure.co.in
The core strength lies in developing and manufacturing differentiated pharmaceutical products in – house and commercializing the same through marketing infrastructure across the geographies.
The group is ranked as the 12th largest Pharmaceutical company (source: AIOCD-AWACS MAT MAR 19) in India.
The Group has emerged as a leader in various therapy segments like Cardiology, Pain and Analgesics, HIV, Gynecology, Nephrology, Cephalosporin Injectable, Hepatology, Oncology, Diabetology, Vitamins – Minerals & Nutrients as well as Blood products.
The group has gained significant advantage due to its diversified / specialized group companies like Zuventus, Gennova and Heritage. Headed by a professional team each of this group has utilized their own strengths across therapy segments and geographies and know-how to make the group stronger and well entrenched.
The group products are available globally over 65 countries and enjoy the alliance of local and multinational companies to attain leadership.
The group has subsidiaries in Dubai, Brazil, South Africa, Singapore and Nigeria and branch offices in Russia, Morocco and Shanghai.
The group has nine manufacturing facilities including eight in India and one in United States, five of which are approved by USFDA.
Our quality is respected in India and world over and is testimonial of our supplies to leading multinationals.
Our group is respected as a reliable and proven co- marketing partner, evident through our collaborative relationship with companies like Sanofi, Roche, B.M.S etc.
We offer technological expertise across various areas like API’s (First to market opportunities in domestic markets), Bio Similars, Novel Drug Delivery Systems, Paragraph IV opportunities in US, wide expertise with various dosage forms, Chiral molecules, Peptides, Polymer based chemistry & complex products.
Through Zuventus the group has emerged as a leader in Acute & Semi Chronic therapies in Indian Pharmaceutical Market. For further info click and access www.emcure.co.in
For more updates follow
To get global pharma news updates in whatsapp please
SEQUENT RESEARCH LTD
We are hiring Analyst/Sr. Analyst @ Sequent Research Ltd. Mangalore.
Qualification: M.Sc.
Experience: 1-4 years
No. of Positions: 5 nos.
Responsibilities:
• Analysing the samples accurately as per the STP, update the raw data and enter the data into LIMS as applicable.
• Strictly follow SOP
• Maintenance of GLP in every aspect.
• Report immediately to the reporting authority if any incidents/OOT/OOS/ deviation.
• Maintenance and calibration of analytical instruments.
Secondary Responsibilities:
• Receiving of stability samples, entering the sample details in LIMS/registers.
• Chemicals and solvents indenting to stores.
• Raising requisition for chemicals and other lab materials
Interested candidates may share their resume at sachin.shirva@srl.sequent.in
Contact: Mr. Sachinkumar Shirva: 9844953216
For more updates follow
To get global pharma news updates in whatsapp please
VKT PHARMA WALK IN INTERVIEW FOR PRODUCTION, QC, ENGINEERING, PACKING DEVELOPMENT & QA ON 29 th, OCTOBER, 2021 @ SRIKAKULAM
ABOUT COMPANY :
VKT Pharma is a Quality driven pharmaceutical company with vertically integrated company spanning across entire pharmaceutical value chain from product development to delivery, with established credentials in Research & Development, Manufacturing and Marketing of Solid Dosage Forms with special focus on Tablets, Capsules & Ready to Fill Immediate or Modified release Pellets for a wide range of generic drug formulations in various Therapeutic segments.
Our pharmaceutical solutions include Development and Manufacturing of finished Solid Dosage Forms, Novel Drug Delivery Systems (NDDS), Contract Research and Manufacturing Service (CRAMS). We are working globally across 10 + countries through alliances, joint ventures and partnerships with highly reputed Pharma majors.
VKT Pharma, with its own talent pool further reinforced by a strong advisory board, offers various consultancy services for Pharmaceutical companies across the globe. Our integrated business model enables us to cater to various business opportunities throughout the value chain, from Research to Delivery of finished products across wide therapeutic segments. Our product basket helps us maintain an edge over our peers in the markets where we are present. In the years to come, driven by a highly competent and motivated team believing in project management and our core values, we will move from strength to strength in the key domains of global generics and drug delivery systems. We aspire for significant rank among the top pharmaceutical companies in India as well as to become one of the leading Indian Pharmaceutical companies in the Global market in developing complex generic molecules, novel drug delivery systems in acute & chronic therapeutic segments to help people lead healthier and Quality life.
For more updates follow
To get global pharma news updates in whatsapp please
BIOLOGICAL E.LTD WALK IN INTERVIEW ON 31st OCTOBER, 2021@ HYDERABAD
ABOUT COMPANY :
Established during the ‘Swadeshi Movement’ of India, Biological E. Limited (BE) started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.
With an objective of transitioning from treating diseases to preventing them, Biological E. Limited launched its Biotechnology Division (now Vaccines and Biologics Division) and commenced large-scale production of DPT vaccines as early as 1962.
Biological E. Limited continues to evolve as an organisation and currently has four strategic business units: Branded Formulations, Speciality Generic Injectables, Synthetic Biology and Vaccines and Biologics.
For more updates follow
To get global pharma news updates in whatsapp please
VITAL THERAPEUTICS PVT LTD WALK IN INTERVIEW ON 30th OCTOBER, 2021@ HYDERABAD
ABOUT COMPANY :
Vital Therapeutics & Formulations Private Limited is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes.
The company was founded in the year 2004 and promoted by Mr. S. Venugopal & Mr.Ramesh Babu to become one of the pioneers in the industry led by their polished expertise and high profile entrepreneurial talent. Through their vision, perseverance and a talented management team, the company is skilled at providing a wide range of services to cater to the prerequisites of national and international pharma majors. Various members of the team bring with them a strong work ethic, commitment to hard-work, professional knowledge and fresh perspective that catapults the company to success in all fields of operations.
For more updates follow
To get global pharma news updates in whatsapp please
Tuesday, 26 October 2021
RAMPEX LABS WALK IN INTERVIEW ON 30th, OCTOBER, 2021 @ PHARMA PATASHALA, HYDERABAD
For more updates follow
To get global pharma news updates in whatsapp please
BIOCON PHARMA LTD WALK IN INTERVIEW FOR PRODUCTION ON 31st OCTOBER, 2021@ HYDERABAD
For more updates follow
To get global pharma news updates in whatsapp please
BIOCON PHARMA LTD WALK IN INTERVIEW FOR PRODUCTION ON 31st OCTOBER, 2021@ GOA
For more updates follow
To get global pharma news updates in whatsapp please
HETERO DRUGS LTD WALK IN INTERVIEW FOR PRODUCTION & QC ON 31 st, OCTOBER, 2021 @ VIZAG
ABOUT COMPANY :
Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients (APIs) in the world.
Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, which has been approved by top pharma regulatory bodies of the world. Our portfolio includes 300+ products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology etc. Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.
Over the years, Hetero has established its strong leadership in ARVs and Antiviral therapies and caters to 40% of existing global demand for Anti-Retroviral (ARV) APIs and Finished Dosage Forms (FDFs) used in HIV/AIDS treatment.
A track record of responding to Global Public Health Emergencies
The highlight of Hetero’s 27+ years of existence has been its responsive actions to mitigate pandemics and life-threatening diseases afflicting communities across the world. By partnering with innovators for developing Oseltamivir to fight against Swine Flu Pandemic to enabling access to affordable Hepatitis C medicines in underdeveloped countries, Hetero has always endeavoured to do its bit at times of global health crises and save precious lives.
Since the onset of the Covid-19 pandemic, Hetero has been proactive in responding to the various challenges surrounding it. It has been the first company to launch the licensed version of generic Remdesivir under the brand name ‘Covifor’ in India for treating severely infected patients and followed it up with Favipiravir (Favivir) to provide succor to those affected by mild and moderate symptoms. As of today, the company is among the largest manufacturers of Remdesivir globally.
Illustrating its continuing commitment to play its part in the global fight against the pandemic, Hetero has entered into an agreement with the Russian Direct Investment Fund (RDIF) as a manufacturing partner for producing 100 million doses of the Sputnik V vaccine per year. This development also showcases Hetero’s enduring spirit of collaboration and penchant for contributing to global health and well-being.
For more updates follow
To get global pharma news updates in whatsapp please
AUROBINDO PHARMA LTD HIRING CANDIDATES FOR NASAL PRODUCTION @ NAIDUPETA , NELLORE
ABOUT COMPANY :
Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
VACANCY DETAILS :
We have an urgent requirement for Nasal Production Technical Assistants @ APL Health Care Limited Unit 4- Naidupet Andhra Pradesh.
Requirement Areas:
Nasal Manufacturing
Nasal Filling
Nasal Packing
Education: ITI / Diploma
Experience:5 - 9 Yrs of relevant experience in Nasal Formulations
Interested candidates send their resumes to pavani.dudi@aurobindo.com
For more updates follow
To get global pharma news updates in whatsapp please
Subscribe to:
Posts (Atom)